All peptides

BPC-157 vs KPV

Updated · Educational, not medical advice

The short answer

Both are asked about for gut symptoms. BPC-157 is a 15-amino-acid peptide from a stomach-protein fragment; KPV is a three-amino-acid fragment of alpha-MSH studied for inflammation. Evidence for both is mainly from animal and lab studies, neither is FDA-approved, and both were recommended for compounding by an FDA advisory committee in July 2026, pending FDA action.

Side by side

What it isBPC-157:BPC-157 ("body protection compound") is a pentadecapeptide, a chain of 15 amino acids, derived from a sequence in a stomach protein. It is made synthetically.KPV:KPV is the C-terminal tripeptide of alpha-MSH, a hormone involved in inflammation signaling.
Human evidenceBPC-157:Most published work is in rodents and cell cultures, which often does not translate to people.KPV:Research consists of cell and animal studies, including models of colitis. Effects in people have not been established.
FDA statusBPC-157:It is not an FDA-approved drug. When prescribed, it is a compounded preparation made by a licensed pharmacy for an individual patient.KPV:It is not an FDA-approved drug. When prescribed, it is a compounded preparation made by a licensed pharmacy for an individual patient.
Side effectsBPC-157:With injected peptides, the most commonly reported problems are injection-site redness, itching or bruising. Because human studies are small, the full side-effect profile is not known; report anything unexpected to your clinician.KPV:With injected peptides, the most commonly reported problems are injection-site redness, itching or bruising. Because human studies are small, the full side-effect profile is not known; report anything unexpected to your clinician.
At PacificRxBPC-157:From $99/month with clinician reviewKPV:From $109/month with clinician review

Questions

What is the difference between BPC-157 and KPV?

Both are asked about for gut symptoms. BPC-157 is a 15-amino-acid peptide from a stomach-protein fragment; KPV is a three-amino-acid fragment of alpha-MSH studied for inflammation. Evidence for both is mainly from animal and lab studies, neither is FDA-approved, and both were recommended for compounding by an FDA advisory committee in July 2026, pending FDA action.

Can you take BPC-157 and KPV together?

Some clinicians prescribe them together; the combination has not been studied in controlled trials.

Do I need a prescription for BPC-157 or KPV?

Yes. Both should be prescribed by a licensed clinician and prepared by a licensed pharmacy. Avoid products sold as "research use only".

Sources

More peptide comparisons